Blanket purchase agreement (BPA) for visudyne and xipere.

Active Awarded Last action

Contract number
36E79723A0003
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 81% complete
IDV ceiling
$175,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs National Acquisition Center established a Blanket Purchase Agreement with Bausch & Lomb Americas Inc. on October 14, 2022, with a ceiling of $175,000.00, for Visudyne and Xipere ophthalmic pharmaceuticals against the GSA Pharmaceuticals and Drugs Federal Supply Schedule.

The BPA operates through October 13, 2027, as a single-award vehicle with no set-aside category. Place of performance follows the parent schedule's nationwide scope. Visudyne treats age-related macular degeneration and macular edema; Xipere treats macular edema resulting from retinal vein occlusion. The source documents exercise of option year 4 under the agreement.

Transactions

Action Obligated Date
Exercise an Option P00012 · Exercise option year 4 - BPA 36E79723A0003 $0
Supplemental Agreement for work within scope P00011 · NDC change $0
Supplemental Agreement for work within scope P00010 · 2026 public law pricing updates. $0
Supplemental Agreement for work within scope P00009 · Delete one NDC (XIPERE). Product is available via the PPV. $0
Exercise an Option P00008 · Exercise option year 3 $0
Supplemental Agreement for work within scope P00007 · Product deletion - one NDC (XIPERE) $0
Supplemental Agreement for work within scope P00006 · 2025 public law pricing updates $0
Exercise an Option P00005 · Exercise option year 2 $0
Supplemental Agreement for work within scope P00004 · 2024 public law pricing updates $0
Supplemental Agreement for work within scope P00003 · NDC change $0
Exercise an Option P00002 · Option year 1 - BPA 36E79723A0003 $0
Supplemental Agreement for work within scope P00001 · 2023 public law updates $0
Original award $0
Show all 13

Quick answers

Who was awarded contract 36E79723A0003?

36E79723A0003 was awarded to Bausch & Lomb Americas Inc. by National Acquisition Center (Headquarters) on October 14, 2022.

How much is contract 36E79723A0003 worth?

36E79723A0003's own ceiling is $175,000.

Who can order from contract 36E79723A0003?

36E79723A0003 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79723A0003 under another contract?

Yes. 36E79723A0003 is a blanket purchase agreement under 36F79722D0218, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79723A0003 competed?

The extent of competition for 36E79723A0003 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV